Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?

Okada M, Ishii K, Numata K, Hyodo T, Kumano S, Kitano M, Kudo M, Murakami T.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):307-13.

2.

Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.

Saito S, Obata A, Kashiwagi Y, Abe K, Murase K.

Invest Radiol. 2013 Jul;48(7):548-53. doi: 10.1097/RLI.0b013e3182856a06.

PMID:
23442774
3.

Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.

Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J.

Invest Radiol. 2011 Sep;46(9):556-66. doi: 10.1097/RLI.0b013e31821a218a.

PMID:
21623212
4.

Liver function test by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging with consideration of intrahepatic regional differences.

Okubo H, Mogami M, Ozaki Y, Igusa Y, Aoyama T, Amano M, Kokubu S, Miyazaki A, Watanabe S.

Hepatogastroenterology. 2013 Oct;60(127):1547-51.

PMID:
23933786
5.

[Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].

Zangos S, Hammerstingl R, Mack MG, Straub R, Engelmann K, Eichler K, Balzer T, Vogl TJ.

Rofo. 2001 Nov;173(11):1034-40. German.

PMID:
11704914
6.

Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.

Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.

Acta Radiol. 2007 May;48(4):362-8.

PMID:
17453513
7.

Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma.

Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D.

Eur Radiol. 2008 Aug;18(8):1577-86. doi: 10.1007/s00330-008-0929-6.

PMID:
18369632
8.

Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?

Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, Araki T.

J Magn Reson Imaging. 2009 Nov;30(5):1042-6. doi: 10.1002/jmri.21956.

PMID:
19856436
9.

Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.

Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Claussen CD, Laniado M.

Acta Radiol. 2000 May;41(3):255-62.

PMID:
10866081
10.

Gd-EOB-DTPA as a functional MR cholangiography contrast agent: imaging gallbladder filling in patients with and without hepatobiliary dysfunction.

Smith AD, Veniero JC.

J Comput Assist Tomogr. 2011 Jul-Aug;35(4):439-45. doi: 10.1097/RCT.0b013e31821f4e29.

PMID:
21765298
11.
12.

Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices.

Kamimura K, Fukukura Y, Yoneyama T, Takumi K, Tateyama A, Umanodan A, Shindo T, Kumagae Y, Ueno S, Koriyama C, Nakajo M.

J Magn Reson Imaging. 2014 Oct;40(4):884-9. doi: 10.1002/jmri.24443.

PMID:
24677659
13.

Effects of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on T2-weighted MRCP.

Nakamura Y, Ohmoto T, Saito T, Kajima T, Nishimaru E, Ito K.

Magn Reson Med Sci. 2009;8(4):143-8.

14.

Early phase detection of bile leak after hepatobiliary surgery: value of Gd-EOB-DTPA-enhanced MR cholangiography.

Alegre Castellanos A, Molina Granados JF, Escribano Fernandez J, Gallardo Muñoz I, Triviño Tarradas Fde A.

Abdom Imaging. 2012 Oct;37(5):795-802.

PMID:
22213118
15.

Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.

Benness G, Khangure M, Morris I, Warwick A, Burrows P, Vogler H, Weinmann HJ.

Invest Radiol. 1996 Apr;31(4):211-7.

PMID:
8721960
16.

T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.

Tamada T, Ito K, Yoshida K, Sone T, Murakami K, Kanki A, Watanabe S, Higashi H, Yamashita T.

J Comput Assist Tomogr. 2010 Mar-Apr;34(2):182-6. doi: 10.1097/RCT.0b013e3181bc961b.

PMID:
20351500
17.

Functional magnetic resonance cholangiography enhanced with Gd-EOB-DTPA: effect of liver function on biliary system visualization.

Feng ST, Wu L, Chan T, Cai H, Luo Y, Zheng K, Tang D, Li ZP.

J Magn Reson Imaging. 2014 May;39(5):1254-8. doi: 10.1002/jmri.24277.

PMID:
24115466
18.

Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

Nakamura S, Awai K, Utsunomiya D, Namimoto T, Nakaura T, Morita K, Yamashita Y.

Jpn J Radiol. 2012 Jan;30(1):25-33. doi: 10.1007/s11604-011-0003-1.

PMID:
22160649
19.

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.

Kim HY, Choi JY, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE, You YK, Kim DG, Jung ES.

Liver Transpl. 2012 Jul;18(7):850-7. doi: 10.1002/lt.23426.

20.

Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf KJ, Albrecht T.

AJR Am J Roentgenol. 2009 Oct;193(4):1053-60. doi: 10.2214/AJR.08.1946.

PMID:
19770329

Supplemental Content

Support Center